Evidence of the in vivo esterification of budesonide in human airways

British Journal of Clinical Pharmacology

Volumn 66, Issue 1, 2008, Pages 27-35

  Van Den Brink, Karen I Maassen ^a   Boorsma, Martin ^b,c   Staal Van Den Brekel, A Jeske ^a   Edsbäcker, Staffam ^d   Wouters, Emiel F ^a   Thorsson, Lars ^d  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ASTRAZENECA   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

Budesonide; Esterification; Fluticasone propionate; Human; In vivo

Indexed keywords

BUDESONIDE; BUDESONIDE OLEATE; FLUTICASONE PROPIONATE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; AIRWAY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RETENTION; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG TOLERABILITY; ESTERIFICATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG FUNCTION; LUNG RESECTION; MALE; POWDER INHALER; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADMINISTRATION, INHALATION; ADULT; AGED; ANDROSTADIENES; BUDESONIDE; ESTERIFICATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 45249111339     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03164.x     Document Type: Article

References (25)

1. National Asthma Education and Prevention Program (NAEPP). Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute. Bethesda, MD : National Institutes of Health, 1997.
2. National Asthma Education Prevention Program (NAEPP). Expert Panel Report: guidelines for the diagnosis and management of asthma - update on selected topics. J Allergy Clin Immunol 2002 110 : S141 219.
3. Pauwels R. Use of corticosteroids in asthma. In : Pharmacy and Pharmacotherapy of Asthma, eds D'Arcy PF, McElnay JL. Chichester : Ellis Harwood, 1989 : 104 18.
4. Edsbäcker S. Pharmacological factors that influence the choice of inhaled corticosteroids. Drugs 1999 58 (Suppl. 4 7 16.
5. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998 157 : S1 S53.
6. Brogden RN, McTavish D. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. Drugs 1992 44 : 375 407.
7. Campbell LM, Watson DG, Venables TL, Taylor MD, Richardson PDL. Once daily budesonide Turbohaler compared with placebo as initial prophylactic therapy for asthma. Br J Clin Res 1991 2 : 111 22.
8. Jones AH, Langdon CG, Lee PS, Lingham SA, Nankani JP, Follows RM, Tollemar U, Richardson PD. Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma. Respir Med 1994 88 : 293 9.
9. Miller-Larsson A, Mattsson H, Hjertberg E, Dahlbäck M, Tunek A, Brattsand R. Reversible fatty acid conjugation of budesonide: novel mechanism for prolonged retention of topically applied steroid in airway tissue. Drug Metab Dispos 1998 26 : 623 30.
10. Thorsson L, Edsbäcker S, Källén A, Löfdahl CG. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler. Br J Clin Pharmacol 2001 52 : 529 38.
11. Tunek A, Sjödin K, Hallström G. Reversible formation of fatty acid esters of budesonide, an antiasthma glucocorticoid, in human lung and liver microsomes. Drug Metab Dispos 1997 11 : 1311 7.
12. Wieslander E, Delander E-L, Sjödin K, Tunek A, Brattsand R. Fatty acid conjugation in normal human bronchial epithelial cells. Am J Respir Crit Care Med 1998 157 : A402.
13. Purucker ME, Rosebraugh CJ, Zhou F, Meyer RJ. Inhaled fluticasone propionate by Diskus in the treatment of asthma: a comparison of the efficacy and safety of the same nominal dose given either once or twice a day. Chest 2003 124 : 1584 93.
14. Nave R, Meyer W, Fuhst R, Zech K. Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide. Pulm Pharmacol Ther 2005 18 : 390 6.
15. Van den Bosch JM, Westermann CJ, Aumann J, Edsbäcker S, Tonnesson M, Selroos O. Relationship between lung tissue and blood plasma concentrations of inhaled budesonide. Biopharm Drug Dispos 1993 14 : 455 9.
16. Esmailpour N, Högger P, Rabe KF, Heitmann U, Nakashima M, Rohdewald P. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J 1997 10 : 1496 9.
17. Jendbro M, Johansson J-M, Strandberg P, Falk-Nilsson H, Edsbäcker S. Pharmacokinetics of budesonide and its major ester metabolite after inhalation and intravenous administration of budesonide in the rat. Drug Metab Dispos 2001 29 : 769 76.
18. Thorsson L, Thunnisen FBJM, Korn S, Carlshaf A, Edsbäcker S, Wouters EFM. Formation of fatty acid conjugates of budesonide in human lung tissue in vivo. Am J Respir Crit Care Med 1998 157 : A404.
19. Davies NM, Feddah MIR. A novel method for assessing dissolution of aerosol inhaler products. Int J Pharmaceut 2003 255 : 175 87.
20. Edsbäcker S, Brattsand R. Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data. Ann Allergy Asthma Immunol 2002 88 : 609 16.
21. Petersen H, Kullberg A, Edsbäcker S, Greiff L. Nasal retention of budesonide and fluticasone in man: formation of airway mucosal budesonide-esters in vivo. Br J Clin Pharmacol 2001 51 : 159 63.
22. Drollmann A, Watz H, Nave R, Boss H, Magnussen H, Hoffmann H. In vivo metabolism of ciclesonide in the human lung. Proc Am Tnorac Soc 2006 3 (Suppl. 3 A75.
23. Dahlberg E, Thalén A, Brattsand R, Gustafsson J-Å, Johansson U, Roempke K, Saartok T. Correlation between chemical structure, receptor binding and biological activity of some novel, highly active 16α, 17α-acetal substituted glucocorticoids. Mol Pharmacol 1984 25 : 70 6.
24. Wieslander E, Delander E-L, Järkelid L, Hjertberg E, Tunek A, Brattsand R. Pharmacologic importance of the reversible fatty acid conjugation of budesonide studies in a rat cell line in vitro. Am J Respir Cell Mol Biol 1998 19 : 477 84.
25. Selroos O, Edsbäcker S, Hultquist C. Once-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation. J Asthma 2004 41 : 771 90.